We identify pediatric patients with growth problems by conducting growth and development assessments. Implement the MENBS clinical interventions for pediatric patients with growth problems.

• Monitor: Continuously monitor health-related indicators through regular follow-up.
• Education: Provide health education to improve cognition of patients and their families.
• Nutrition: Assess patients' nutritional risks and develop personalized diet plans.
• Behavior: Recommend appropriate exercise plans to promote physical development.
• Support: Conduct home visits, offer free clinics and establish a support network.

It is assessed using the 'Growth Standard for Children under 7 Years of Age' and the 'Standard for Height Level Classification among Children and Adolescents Aged 7-18 Years' issued by the National Health Commission

It is assessed using the 'Growth Standard for Children under 7 Years of Age' and the 'Dietary Guidelines for Chinese Residents'.

Puberty status will be measured using by Tanner scale (TS). It is a five-stage system to assess breast development (in girls), genital development (in boys), pubic hair growth (in both sexes).

Endocrine function such as hormonal levels (IGF-1, GH, etc.) will be measured by clinical examination

Nutritional status will be measured by clinical examination, such as concentration of Vitamin D and Zinc

IQ will be measured by scores obtained from Raven's Progressive Matrices. Raw scores are converted into percentile ranks or IQ scores based on age-group norms:

• ≥95th percentile (IQ ~125+): Very high intelligence.
• 75th-94th percentile (IQ ~110-124): Above average.
• 25th-74th percentile (IQ ~90-109): Average range (most common).
• 5th-24th percentile (IQ ~80-89): Below average.
• <5th percentile (IQ <80): Potential intellectual disability.